SCHEMBL7811447

SCHEMBL7811447

Clc1cccc(Nc2nccc(-c3ccnc(NCCN4CCOCC4)c3)n2)c1.NCCN1CCOCC1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 2/20 0.72
SMG1 Q96Q15 6/20 0.62
CDK1 P06493 4/20 0.62
CDK2 P24941 4/20 0.62
MTOR P42345 2/20 0.62
NPC1 O15118 1/20 0.62
CCNT1 O60563 1/20 0.62
MAPT P10636 1/20 0.62
CDK4 P11802 1/20 0.62
CCNB1 P14635 1/20 0.62
XBP1 P17861 1/20 0.62
CCNA2 P20248 1/20 0.62
CCND1 P24385 1/20 0.62
CCNE1 P24864 1/20 0.62
MAPK1 P28482 1/20 0.62
HTT P42858 1/20 0.62
CDK7 P50613 1/20 0.62
CDK9 P50750 1/20 0.62
RAB9A P51151 1/20 0.62
CCNH P51946 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6109026 0.96 CSNK2A1 (0.69) CSNK2A1SMG1CDK1CDK2MTOR
SCHEMBL6107651 0.84 CSNK2A1 (1.00) CSNK2A1SMG1CDK1CDK2MTOR
Monoethanolamine SCHEMBL7817266 0.81 CSNK2A1 (0.85) CSNK2A1SMG1CDK1CDK2MTOR
SCHEMBL13698056 0.79 KDR (0.59) CSNK2A1SMG1CDK1CDK2MTOR
SCHEMBL6094407 0.79 CDK1 (0.88) CSNK2A1SMG1CDK1CDK2MTOR
SCHEMBL5733802 0.79 CSNK2A1 (0.80) CSNK2A1SMG1CDK1CDK2MTOR
SCHEMBL7817083 0.79 CDK1 (0.91) CSNK2A1SMG1CDK1CDK2MTOR
SCHEMBL7813759 0.78 CDK1 (0.85) CSNK2A1SMG1CDK1CDK2MTOR
SCHEMBL6108097 0.78 CSNK2A1 (0.69) CSNK2A1SMG1CDK1CDK2MTOR
SCHEMBL6107663 0.77 SMG1 (1.00) CSNK2A1SMG1CDK1CDK2MTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0672041-B1 PHARMACOLOGICALLY ACTIVE PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 2001-11-14 EP disclosed